Bacterial biofilm development as a multicellular adaptation: Antibiotic resistance and new therapeutic strategies

Current Opinion in Microbiology

Volumn 16, Issue 5, 2013, Pages 580-589

  De la Fuente Núñez, César ^a   Reffuveille, Fany ^a   Fernández, Lucía ^a   Hancock, Robert EW ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; COLISTIN; QUINOLONE DERIVATIVE; TETRACYCLINE;

AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANAEROBIC GROWTH; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACTERIAL CELL; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL METABOLISM; BACTERIAL OUTER MEMBRANE; BACTERIAL SURVIVAL; BACTERIUM; BIOFILM; BIOGENESIS; BURKHOLDERIA CEPACIA; CELL DIFFERENTIATION; CELL SURFACE; DNA REPAIR; ENTEROCOCCUS FAECALIS; ENVIRONMENTAL CHANGE; ENVIRONMENTAL STRESS; ESCHERICHIA COLI; EXTRACELLULAR MATRIX; HAEMOPHILUS INFLUENZAE; HEAT SHOCK; HORIZONTAL GENE TRANSFER; KLEBSIELLA PNEUMONIAE; LISTERIA MONOCYTOGENES; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUTRIENT LIMITATION; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; REVIEW; SALINITY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS; UPREGULATION;

BACTERIA (MICROORGANISMS);

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL PHYSIOLOGICAL PHENOMENA; BIOFILMS; DRUG RESISTANCE, BACTERIAL;

EID: 84887628130     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2013.06.013     Document Type: Review

References (66)

1. Hall-Stoodley L., Costerton J.W., Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2004, 2:95-108.
2. Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318-1322.
3. O'Toole G., Kaplan H.B., Kolter R. Biofilm formation as microbial development. Annu Rev Microbiol 2000, 54:49-79.
4. Kolter R. Biofilms in lab and nature: a molecular geneticist's voyage to microbial ecology. Int Microbiol 2010, 13:1-7.
5. Beloin C., Ghigo J.M. Finding gene-expression patterns in bacterial biofilms. Trends Microbiol 2005, 13:16-19.
6. Whiteley M., Bangera M.G., Bumgarner R.E., Parsek M.R., Teitzel G.M., Lory S., Greenberg E.P. Gene expression in Pseudomonas aeruginosa biofilms. Nature 2001, 413:860-864.
7. O'Toole G.A., Kolter R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol 1998, 30:295-304.
8. Davies D.G., Parsek M.R., Pearson J.P., Iglewski B.H., Costerton J.W., Greenberg E.P. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 1998, 280:295-298.
9. Whitchurch C.B., Tolker-Nielsen T., Ragas P.C., Mattick J.S. Extracellular DNA required for bacterial biofilm formation. Science 2002, 295:1487.
10. Flemming H.C., Wingender J. The biofilm matrix. Nat Rev Microbiol 2010, 8:623-633.
11. Breidenstein E.B.M., de la Fuente-Núñez C., Hancock R.E.W. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol 2011, 19:419-426.
12. Høiby N., Ciofu O., Bjarnsholt T. Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol 2010, 5:1663-1674.
13. Høiby N., Ciofu O., Johansen H.K., Song Z.J., Moser C., Jensen PØ, Molin S., Givskov M., Tolker-Nielsen T., Bjarnsholt T. The clinical impact of bacterial biofilms. Int J Oral Sci 2011, 3:55-65.
14. Römling U., Balsalobre C. Biofilm infections, their resilience to therapy and innovative treatment strategies. J Intern Med 2012, 272:541-561.
15. Percival S.L., Hill K.E., Williams D.W., Hooper S.J., Thomas D.W., Costerton J.W. A review of the scientific evidence for biofilms in wounds. Wound Repair Regen 2012, 20:647-657.
16. Bryers J.D. Medical biofilms. Biotechnol Bioeng 2008, 100:1-18.
17. Fernández L., Breidenstein E.B.M., Hancock R.E.W. Creeping baselines and adaptive resistance to antibiotics. Drug Resist Updat 2011, 14:1-21.
18. Nickel J.C., Wright J.B., Ruseska I., Marrie T.J., Whitfield C., Costerton J.W. Antibiotic resistance of Pseudomonas aeruginosa colonizing a urinary catheter in vitro. Eur J Clin Microbiol 1985, 4:213-218.
19. Cook L., Chatterjee A., Barnes A., Yarwood J., Hu W.S., Dunny G. Biofilm growth alters regulation of conjugation by a bacterial pheromone. Mol Microbiol 2011, 81:1499-1510.
20. Savage V.J., Chopra I., O'Neill A.J. Staphylococcus aureus biofilms promote horizontal transfer of antibiotic resistance. Antimicrob Agents Chemother 2013, 57:1968-1970.
21. Driffield K., Miller K., Bostock J.M., O'Neill A.J., Chopra I. Increased mutability of Pseudomonas aeruginosa in biofilms. J Antimicrob Chemother 2008, 61:1053-1056.
22. Nguyen D., Joshi-Datar A., Lepine F., Bauerle E., Olakanmi O., Beer K., McKay G., Siehnel R., Schafhauser J., Wang Y., Britigan B.E., Singh P.K. Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 2011, 334:982-986.
23. Bernier S.P., Lebeaux D., DeFrancesco A.S., Valomon A., Soubigou G., Coppée J.Y., Ghigo J.M., Beloin C. Starvation, together with the SOS response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin. PLoS Genet 2013, 9:e1003144.
24. Breidenstein E.B.M., Bains M., Hancock R.E.W. Involvement of the lon protease in the SOS response triggered by ciprofloxacin in Pseudomonas aeruginosa PAO1. Antimicrob Agents Chemother 2012, 56:2879-2887.
25. Kindrachuk K.N., Fernández L., Bains M., Hancock R.E.W. Involvement of an ATP-dependent protease, PA0779/AsrA, in inducing heat shock in response to tobramycin in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2011, 55:1874-1882.
26. Kuczyńska-Wiśnik D., Matuszewska E., Laskowska E. Escherichia coli heat-shock proteins IbpA and IbpB affect biofilm formation by influencing the level of extracellular indole. Microbiology 2010, 156:148-157.
27. van der Veen S., Abee T. HrcA and DnaK are important for static and continuous-flow biofilm formation and disinfectant resistance in Listeria monocytogenes. Microbiology 2010, 156:3782-3790.
28. Borriello G., Werner E., Roe F., Kim A.M., Ehrlich G.D., Stewart P.S. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob Agents Chemother 2004, 48:2659-2664.
29. Schaible B., Taylor C.T., Schaffer K. Hypoxia increases antibiotic resistance in Pseudomonas aeruginosa through altering the composition of multidrug efflux pumps. Antimicrob Agents Chemother 2012, 56:2114-2118.
30. Gillis R.J., White K.G., Choi K.H., Wagner V.E., Schweizer H.P., Iglewski B.H. Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 2005, 49:3858-3867.
31. Pamp S.J., Gjermansen M., Johansen H.K., Tolker-Nielsen T. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol Microbiol 2008, 68:223-240.
32. Lewis K. Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol 2008, 322:107-131.
33. Qu Y., Daley A.J., Istivan T.S., Rouch D.A., Deighton M.A. Densely adherent growth mode, rather than extracellular polymer substance matrix build-up ability, contributes to high resistance of Staphylococcus epidermidis biofilms to antibiotics. J Antimicrob Chemother 2010, 65:1405-1411.
34. Kumon H., Tomochika K., Matunaga T., Ogawa M., Ohmori H. A sandwich cup method for the penetration assay of antimicrobial agents through Pseudomonas exopolysaccharides. Microbiol Immunol 1994, 38:615-619.
35. Singh R., Ray P., Das A., Sharma M. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J Antimicrob Chemother 2010, 65:1955-1958.
36. Anderl J.N., Franklin M.J., Stewart P.S. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2000, 44:1818-1824.
37. Mulcahy H., Charron-Mazenod L., Lewenza S. Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS Pathog 2008, 4:e1000213.
38. Johnson L., Mulcahy H., Kanevets U., Shi Y., Lewenza S. Surface-localized spermidine protects the Pseudomonas aeruginosa outer membrane from antibiotic treatment and oxidative stress. J Bacteriol 2012, 194:813-826.
39. Zhang L., Mah T.F. Involvement of a novel efflux system in biofilm-specific resistance to antibiotics. J Bacteriol 2008, 190:4447-4452.
40. Lynch S.V., Dixon L., Benoit M.R., Brodie E.L., Keyhan M., Hu P., Ackerley D.F., Andersen G.L., Matin A. Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms. Antimicrob Agents Chemother 2007, 51:3650-3658.
41. Matsumura K., Furukawa S., Ogihara H., Morinaga Y. Roles of multidrug efflux pumps on the biofilm formation of Escherichia coli K-12. Biocontrol Sci 2011, 16:69-72.
42. Baugh S., Ekanayaka A.S., Piddock L.J., Webber M.A. Loss of or inhibition of all multidrug resistance efflux pumps of Salmonella enterica serovar Typhimurium results in impaired ability to form a biofilm. J Antimicrob Chemother 2012, 67:2409-2417.
43. Mah T.F., Pitts B., Pellock B., Walker G.C., Stewart P.S., O'Toole G.A. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 2003, 426:306-310.
44. Beaudoin T., Zhang L., Hinz A.J., Parr C.J., Mah T.F. The biofilm-specific antibiotic resistance gene ndvB is important for expression of ethanol oxidation genes in Pseudomonas aeruginosa biofilms. J Bacteriol 2012, 194:3128-3136.
45. Zhang L., Hinz A.J., Nadeau J.P., Mah T.F. Pseudomonas aeruginosa tssC1 links type VI secretion and biofilm-specific antibiotic resistance. J Bacteriol 2011, 193:5510-5513.
46. Kolodkin-Gal I., Romero D., Cao S., Clardy J., Kolter R., Losick R. d-Amino acids trigger biofilm disassembly. Science 2010, 328:627-629.
47. Hochbaum A.I., Kolodkin-Gal I., Foulston L., Kolter R., Aizenberg J., Losick R. Inhibitory effects of d-amino acids on Staphylococcus aureus biofilm development. J Bacteriol 2011, 193:5616-5622.
48. Kolodkin-Gal I., Cao S., Chai L., Böttcher T., Kolter R., Clardy J., Losick R. A self-produced trigger for biofilm disassembly that targets exopolysaccharide. Cell 2012, 149:684-692.
49. Barraud N., Schleheck D., Klebensberger J., Webb J.S., Hassett D.J., Rice S.A., Kjelleberg S. Nitric oxide signaling in Pseudomonas aeruginosa biofilms mediates phosphodiesterase activity, decreased cyclic di-GMP levels, and enhanced dispersal. J Bacteriol 2009, 191:7333-7342.
50. Rendueles O., Travier L., Latour-Lambert P., Fontaine T., Magnus J., Denamur E., Ghigo J.M. Screening of Escherichia coli species biodiversity reveals new biofilm-associated antiadhesion polysaccharides. MBio 2011, 2. e00043-11.
51. Overhage J., Campisano A., Bains M., Torfs E.C., Rehm B.H., Hancock R.E.W. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun 2008, 76:4176-4182.
52. de la Fuente-Núñez C., Korolik V., Bains M., Nguyen U., Breidenstein E.B.M., Horsman S., Lewenza S., Burrows L., Hancock R.E.W. Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide. Antimicrob Agents Chemother 2012, 56:2696-2704.
53. Jorge P., Lourenço A., Pereira M.O. New trends in peptide-based anti-biofilm strategies: a review of recent achievements and bioinformatic approaches. Biofouling 2012, 28:1033-1061.
54. Hancock R.E.W., Sahl H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 2006, 24:1551-1557.
55. Balaban N., Cirioni O., Giacometti A., Ghiselli R., Braunstein J.B., Silvestri C., Mocchegiani F., Saba V., Scalise G. Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP. Antimicrob Agents Chemother 2007, 51:2226-2229.
56. Chung J., Goo E., Yu S., Choi O., Lee J., Kim J., Kim H., Igarashi J., Suga H., Moon J.S., Hwang I., Rhee S. Small-molecule inhibitor binding to an N-acyl-homoserine lactone synthase. Proc Natl Acad Sci U S A 2011, 108:12089-12094.
57. Rasmussen T.B., Bjarnsholt T., Skindersoe M.E., Hentzer M., Kristoffersen P., Köte M., Nielsen J., Eberl L., Givskov M. Screening for quorum-sensing inhibitors (QSI) by use of a novel genetic system, the QSI selector. J Bacteriol 2005, 187:1799-1814.
58. Boyd C.D., O'Toole G.A. Second messenger regulation of biofilm formation: breakthroughs in understanding c-di-GMP effector systems. Annu Rev Cell Dev Biol 2012, 28:439-462.
59. Pesavento C., Hengge R. Bacterial nucleotide-based second messengers. Curr Opin Microbiol 2009, 12:170-176.
60. Kaplan J.B., Velliyagounder K., Ragunath C., Rohde H., Mack D., Knobloch J.K., Ramasubbu N. Genes involved in the synthesis and degradation of matrix polysaccharide in Actinobacillus actinomycetemcomitans and Actinobacillus pleuropneumoniae biofilms. J Bacteriol 2004, 186:8213-8220.
61. Ramasubbu N., Thomas L.M., Ragunath C., Kaplan J.B. Structural analysis of dispersin B, a biofilm-releasing glycoside hydrolase from the periodontopathogen Actinobacillus actinomycetemcomitans. J Mol Biol 2005, 349:475-486.
62. Cegelski L., Pinkner J.S., Hammer N.D., Cusumano C.K., Hung C.S., Chorell E., Aberg V., Walker J.N., Seed P.C., Almqvist F., Chapman M.R., Hultgren S.J. Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nat Chem Biol 2009, 5:913-919.
63. Lu T.K., Collins J.J. Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. Proc Natl Acad Sci U S A 2009, 106:4629-4634.
64. Banin E., Brady K.M., Greenberg E.P. Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl Environ Microbiol 2006, 72:2064-2069.
65. Beyth N., Yudovin-Farber I., Perez-Davidi M., Domb A.J., Weiss E.I. Polyethyleneimine nanoparticles incorporated into resin composite cause cell death and trigger biofilm stress in vivo. Proc Natl Acad Sci U S A 2010, 107:22038-22043.
66. Lellouche J., Kahana E., Elias S., Gedanken A., Banin E. Antibiofilm activity of nanosized magnesium fluoride. Biomaterials 2009, 30:5969-5978.